Target intelligence / Profile preview

Protein tyrosine phosphatase receptor type Q (PTPRQ)

Target
PTPRQ
Molecular classification
Receptor, Enzyme, Protein tyrosine phosphatase, Type III receptor-like protein-tyrosine phosphatase
01

Overview

Protein tyrosine phosphatase receptor type Q (PTPRQ) is a member of the type III receptor-like protein tyrosine phosphatase family, consisting of an extracellular region with multiple fibronectin type III domains, a transmembrane helix, and a cytoplasmic phosphatase domain. It is active against phosphatidylinositol phosphates, with limited activity against phosphotyrosine, and plays crucial roles in regulating cellular survival, proliferation, differentiation, and subcellular architecture. PTPRQ is essential for maturation of cochlear hair bundles, thereby having a critical role in auditory function. Mutations in PTPRQ are linked to both autosomal dominant and recessive hearing loss. Additionally, changes in PTPRQ expression and mutations have been implicated in various cancers, suggesting its broader role in pathology and potential as a therapeutic target. PTPRQ also contributes to adipogenesis by regulating PI3K/AKT signaling through dephosphorylation of PIP3.

Other names
Phosphatidylinositol phosphatase PTPRQR-PTP-QReceptor-type tyrosine-protein phosphatase QDFNA73DFNB84DFNB84APTPGMC1Protein-tyrosine phosphatase, receptor-type, expressed by glomerular mesangial cellsDeafness, autosomal recessive 84Deafness, autosomal dominant 73
02

Mechanism of action

Dephosphorylation of phosphatidylinositol phosphates (PIP2/PIP3), Modulation of AKT1 phosphorylation and downstream PI3K/AKT signaling

03

Biological functions

Regulation of cell proliferationRegulation of apoptosisCell differentiationCell survivalAdipogenesis of mesenchymal stem cellsMaturation of cochlear hair bundlesRegulation of phosphatidylinositol signaling
04

Disease associations

Hearing loss (deafness: autosomal recessive and dominant forms)Cancer (mutations/deletions/amplifications linked to tumorigenesis)Potential biomarker for idiopathic normal pressure hydrocephalus and Alzheimer’s disease
05

Safety considerations

Potential safety concerns not well establishedPerturbation may impact auditory function, adipogenesis, and possibly cell proliferation in cancerTherapeutic modulation may pose challenges due to broad substrate specificity and involvement in vital cellular processes
06

Biomarkers

Hearing lossIdiopathic normal pressure hydrocephalusAlzheimer’s disease

Beyond the preview

Go deeper on Protein tyrosine phosphatase receptor type Q (PTPRQ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein tyrosine phosphatase receptor type Q (PTPRQ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call